Acadia Healthcare (NASDAQ:ACHC) Hits New 52-Week Low on Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reached a new 52-week low during mid-day trading on Friday after StockNews.com downgraded the stock from a hold rating to a sell rating. The stock traded as low as $65.67 and last traded at $66.72, with a volume of 148079 shares changing hands. The stock had previously closed at $66.73.

Other research analysts have also issued reports about the company. Mizuho cut their price objective on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. UBS Group upped their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Bank of America reduced their target price on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a report on Thursday. Finally, Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a report on Friday, January 5th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $89.50.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Acadia Healthcare

Large investors have recently made changes to their positions in the company. Avidity Partners Management LP lifted its stake in shares of Acadia Healthcare by 61.8% in the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after purchasing an additional 441,692 shares during the last quarter. Sea Cliff Partners Management LP acquired a new stake in shares of Acadia Healthcare during the fourth quarter valued at about $26,338,000. Vaughan Nelson Investment Management L.P. acquired a new position in shares of Acadia Healthcare in the 4th quarter worth approximately $24,157,000. OFI Invest Asset Management boosted its position in shares of Acadia Healthcare by 290.5% during the 3rd quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock worth $21,990,000 after purchasing an additional 246,322 shares during the period. Finally, Jennison Associates LLC increased its holdings in Acadia Healthcare by 26.1% in the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after purchasing an additional 238,114 shares during the last quarter.

Acadia Healthcare Stock Performance

The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average price of $77.13 and a 200 day moving average price of $77.61. The firm has a market capitalization of $6.11 billion, a PE ratio of -472.29, a price-to-earnings-growth ratio of 2.15 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.56%. The firm’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.75 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.